Risk factors associated with long QT syndrome in cardiovascular anesthesia
Keywords:
cardiovascular anesthesia, extracorporeal circulation, QT interval, long QT syndrome, risk factors, complicationsAbstract
Introduction: The long QT syndrome is a channelopathy characterized by a serious alteration in ventricular repolarization.
Objective: To determine the risk factors associated with prolonged QT interval in cardiovascular anesthesia.
Methods: Descriptive, cross-sectional study from May 2014 to May 2016, in patients scheduled for cardiac surgery under extracorporeal circulation. The attributable risk and the confidence interval were evaluated for 95% and in variables with p value under 0.05.
Results: 483 patients were included, with a mean age of 62 years, of whom 57 (12 %) had prolonged QTc. Advanced age (RA: 1.8, 95 % CI: 0.86-2.67), chronic renal failure (RA: 2.7, 95 % CI: 0.82-4.96), type 2 diabetes mellitus (RA: 1.7, 95 % CI: 1.01-2.15), ischemic heart disease (RA: 3.5, 95 % CI: 1.60-4.02), left ventricular hypertrophy (RA: 2.2, 95 % CI: 2.53-3.15), calcium-lactam antibiotics (RA: 1.5, 95 % CI: 0.92-2.98), balanced orotracheal general anesthesia (RA: 2.1, 95 % CI: 2.92-2.35), ondansetron (RA: 1.7, 95 % CI: 0.98-2.74), droperidol (RA: 1.8, 95 % CI: 2.18-3.94) ), extracorporeal circulation time (RA: 2.5, 95 % CI: 1.02-3.62), hypokalemia (RA: 1.4, 95 % CI: 1.03-2.91) and severe bradycardia (RA: 1.8, 95 % CI: 1.12-3.86) were associated with a high risk of QT prolongation. The complications were more significant in this group, with a mortality of 23%.
Conclusions: Advanced age, chronic renal failure, type 2 diabetes mellitus, ventricular hypertrophy, and ischemic heart disease facilitate the prolongation of QT induced by calcium blockers. The longer time of extracorporeal circulation, the balanced anesthesia with isoflurane, the use of droperidol and ondansetron, bradycardia and postoperative hypokalemia are variables associated with the extension of the QT interval, with an increase in complications. Ventricular tachyarrhythmias and mortality were higher in this subgroup of patients.
Downloads
References
Cabrera PAJ, Cruz BR, Suárez LJM. Anestesia en Cirugía Cardiaca. En: Guevara LA. Cirugía Cardiovascular. La Habana. Editorial Científico-Técnica: 2009. pp. 20-52.
Garrote JA, Marín EH, Moreno OM, álvarez LP, Prats XV. Guías de práctica clínica en arritmias cardiacas. Rev Esp Cardiol. 2011;54(3):307-67.
Olgin EJ, Zipes ZP. Arritmias específicas: diagnóstico y tratamiento. En: Braunwald E. Tratado de Cardiología. 10 ma ed. Barcelona. Editorial Elsevier. 2015. Pp. 784-97.
Zhang Y, Post WS, Blasco CE, Shah R, Scott JW. Electrocardiographic QT abnormality. A meta-analysis. Epidemiology. 2013;22(2):660-4.
Barnes BJ, Hollands JM. Drug-induced arrhythymias. Crit Care Med. 2012;38(2):188-97.
Charbit BA, Funck-Brentano C. Droperidol-induced proarrhythmia. The beginning of an answer? Anesthesiology. 2007;107(1):531-6.
Volkan H, Yurtlu S, Karabağ T, Okyay D, Hakimoğlu S, Kayhan G, et al. Efectos del Esmolol, de la Lidocaína y del Fentanilo en los Intervalos Dispersión de la Onda, QT, QTc y Respuestas Hemodinámicas a la Intubación Endotraqueal Durante Inducción con Propofol: un Estudio Comparativo. Rev Bras Anestesiol. 2013;63(3):235-44.
Lorentz MN, Brandao BS. Arritmias cardiacas y anestesia. Rev Bras Anestesiol. 2011;61(6):440-8.
Viskin S. The QT interval: too long, too short or just right. Heart Rhyth. 2013;6(2):711-5.
Priori SG, Lundqvist BC, Mazzanti A, Blom N, Borggrefe M, Camm JC, et al. Guía ESC 2015 del tratamiento de pacientes con arritmias ventriculares y MSC. Rev Esp Cardiol. 2016;69 (2):176.e1- e77.
Ackerman MJ, Priori SG, Willems SA, Brugada R, Berul C. Consensus statement on the channelopathies. Europace. 2013;13(2):1077-109.
Nagele P, Pal S, Brown F, Blood J, Miller JP, Johnston J. Postoperative QT interval prolongation in patients undergoing cardiac surgery. Anesthesiology. 2012;11(7):31-6.
Kaye AD, Volpi-Abadie J, Bensler JM. QT interval abnormalities: risk factors and perioperative management in long QT syndromes. J Anesth. 2013;27(4):575-87.
Priori SG, Schwartz PJ, Napolitano C, Bloise R. Risk stratification in the long-QT syndrome. N Engl J Med. 2013;348(2):1866-74.
Goudis CA, Kaiergis EM, Simantirakis EN, Vardas PE, Kochiadakis GE. Mechanism, risk factors and management of acquired long QT syndrome. Scientific World Journal. 2012;2012:212178. doi: 10.1100/2012/212178
Cafiero TD, Di Minno RM, Di Lorio C. QT interval and QT dispersion during the induction of anesthesia and tracheal intubation. Minerva Anestesiol. 2012;77:160-5.
Cordova S, Mela SS, Gresa BC. El síndrome de QT largo en anestesia. Rev Chil Anest. 2015;44(2):131-46.
Staikou C, Chondrogiannis K, Mani A. Perioperative management of hereditary arrhythmogenic syndromes. Br J Anaesth. 2012;108(5):730-44.
Stamelos M, Staikou C, Stavroulakis E. Anaesthetics and ECG torsadogenic markers. Br J Anaesth. 2013;193(10):1-14.
Landoni G, Guarracino F, Cariello C, Franco A, Borgui R. Volatile compared with TIVA in high risk cardiac surgery. B J Anaesth. 2014;113(6):955-63.
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal accept the following terms:
- They will retain their copyright and guarantee the journal the right of the first publication of their work.
- All the content of the journal is under a license https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES
- It is recommended to the author to insert their articles in recognized preprints serves and introduce their database in server crated to this end.